|
1
|
Hossain MS, Karuniawati H, Jairoun AA,
Urbi Z, Ooi J, John A, Lim YC, Kibria KMK, Mohiuddin AKM, Ming LC,
et al: Colorectal cancer: A review of carcinogenesis, global
epidemiology, current challenges, risk factors, preventive and
treatment strategies. Cancers (Basel). 14:17322022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
3
|
Morgan E, Arnold M, Gini A, Lorenzoni V,
Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N and Bray F:
Global burden of colorectal cancer in 2020 and 2040: Incidence and
mortality estimates from GLOBOCAN. Gut. 72:338–344. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weng W and Goel A: Curcumin and colorectal
cancer: An update and current perspective on this natural medicine.
Semin Cancer Biol. 80:73–86. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Y and Xie J: Targeting ferroptosis
regulators by natural products in colorectal cancer. Front
Pharmacol. 15:13747222024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Su Z, Li Y, Zhou Z, Feng B, Chen H and
Zheng G: Herbal medicine for colorectal cancer treatment: Molecular
mechanisms and clinical applications. Cell Prolif. Jun 9–2025.(Epub
ahead of print). View Article : Google Scholar
|
|
7
|
Neira M, Mena C, Torres K and Simón L: The
potential benefits of curcumin-enriched diets for adults with
colorectal cancer: A systematic review. Antioxidants (Basel).
14:3882025. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Howells LM, Iwuji COO, Irving GRB, Barber
S, Walter H, Sidat Z, Griffin-Teall N, Singh R, Foreman N, Patel
SR, et al: Curcumin combined with FOLFOX chemotherapy is safe and
tolerable in patients with metastatic colorectal cancer in a
randomized phase IIa trial. J Nutr. 149:1133–1139. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Layos L, Martínez-Balibrea E and Ruiz de
Porras V: Curcumin: A novel way to improve quality of life for
colorectal cancer patients? Int J Mol Sci. 23:140582022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang J, Wu Y, Tian Y, Xu H, Lin ZX and
Xian YF: Chinese herbal medicine for the treatment of intestinal
cancer: Preclinical studies and potential clinical applications.
Mol Cancer. 23:2172024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gilad O, Rosner G, Ivancovsky-Wajcman D,
Zur R, Rosin-Arbesfeld R, Gluck N, Strul H, Lehavi D, Rolfe V and
Kariv R: Efficacy of wholistic turmeric supplement on adenomatous
polyps in patients with familial adenomatous polyposis-a
randomized, double-blinded, placebo-controlled study. Genes
(Basel). 13:21822022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Panahi Y, Saberi-Karimian M, Valizadeh O,
Behnam B, Saadat A, Jamialahmadi T, Majeed M and Sahebkar A:
Effects of curcuminoids on systemic inflammation and quality of
life in patients with colorectal cancer undergoing chemotherapy: A
randomized controlled trial. Adv Exp Med Biol. 1328:1–9. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu C, Rokavec M, Huang Z and Hermeking H:
Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress
colorectal cancer metastasis. Cell Death Differ. 30:1771–1785.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu Y, Han Y, Zhao NN and Zhao XF: Curcumin
exerts therapeutic effects on colorectal cancer by blocking the
cell cycle and regulating apoptosis. Asian J Surg. Aug
28–2024.(Epub ahead of print).
|
|
15
|
Miyazaki K, Xu C, Shimada M and Goel A:
Curcumin and andrographis exhibit anti-tumor effects in colorectal
cancer via activation of ferroptosis and dual suppression of
glutathione peroxidase-4 and ferroptosis suppressor protein-1.
Pharmaceuticals (Basel). 16:3832023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ojo OA, Adeyemo TR, Rotimi D, Batiha GE,
Mostafa-Hedeab G, Iyobhebhe ME, Elebiyo TC, Atunwa B, Ojo AB, Lima
CMG and Conte-Junior CA: Anticancer properties of curcumin against
colorectal cancer: A review. Front Oncol. 12:8816412022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang Q, Xu Y, Tan X, Wu X, Li S, Yuan J,
Chen X, Huang Q, Fu K and Xiao S: The role and therapeutic
potential of pyroptosis in colorectal cancer: A review.
Biomolecules. 14:8742024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pang Q, Wang P, Pan Y, Dong X, Zhou T,
Song X and Zhang A: Irisin protects against vascular calcification
by activating autophagy and inhibiting NLRP3-mediated vascular
smooth muscle cell pyroptosis in chronic kidney disease. Cell Death
Dis. 13:2832022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Min R, Bai Y, Wang NR and Liu X:
Gasdermins in pyroptosis, inflammation, and cancer. Trends Mol Med.
Apr 29–2025.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng MZ, Yang BB, Zhan ZT, Lin SM, Fang
ZP, Gao Y and Zhou WJ: MACC1 and gasdermin-E (GSDME) regulate the
resistance of colorectal cancer cells to irinotecan. Biochem
Biophys Res Commun. 671:236–245. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Q, Peng B, Lin L, Chen J, Jiang Z,
Luo Y, Huang L, Li J, Peng Y, Wu J, et al: Chondroitin
sulfate-modified hydroxyapatite for caspase-1 activated induced
pyroptosis through Ca overload/ER stress/STING/IRF3 pathway in
colorectal cancer. Small. 20:e24032012024. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang N, Zhang L, Leng XX, Xie YL, Kang ZR,
Zhao LC, Song LH, Zhou CB and Fang JY: Fusobacterium
nucleatum induces chemoresistance in colorectal cancer by
inhibiting pyroptosis via the Hippo pathway. Gut Microbes.
16:23337902024. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang Z, Ji L, Han M, Xie J, Zhong F, Zhang
X, Su Q, Yang Z, Liu Z, Gao H and Jiang G: Pyroptosis is involved
in the inhibitory effect of FL118 on growth and metastasis in
colorectal cancer. Life Sci. 257:1180652020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brockmueller A, Ruiz de Porras V and
Shakibaei M: Curcumin and its anti-colorectal cancer potential:
From mechanisms of action to autophagy. Phytother Res.
38:3525–3551. 2024. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou H, Zhuang Y, Liang Y, Chen H, Qiu W,
Xu H and Zhou H: Curcumin exerts anti-tumor activity in colorectal
cancer via gut microbiota-mediated CD8+ T Cell tumor
infiltration and ferroptosis. Food Funct. 16:3671–3693. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dal Z and Aru B: The role of curcumin on
apoptosis and NLRP3 inflammasome-dependent pyroptosis on colorectal
cancer in vitro. Turk J Med Sci. 53:883–893. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Galluzzi L, Humeau J, Buqué A, Zitvogel L
and Kroemer G: Immunostimulation with chemotherapy in the era of
immune checkpoint inhibitors. Nat Rev Clin Oncol. 17:725–741. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang X, Tang B, Luo J, Yang Y, Weng Q,
Fang S, Zhao Z, Tu J, Chen M and Ji J: Cuproptosis, ferroptosis and
PANoptosis in tumor immune microenvironment remodeling and
immunotherapy: Culprits or new hope. Mol Cancer. 23:2552024.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Du T, Gao J, Li P, Wang Y, Qi Q, Liu X, Li
J, Wang C and Du L: Pyroptosis, metabolism, and tumor immune
microenvironment. Clin Transl Med. 11:e4922021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang M, Yu F, Zhang Y and Li P: Programmed
cell death in tumor immunity: Mechanistic insights and clinical
implications. Front Immunol. 14:13096352024. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen Q, Sun Y, Wang S and Xu J: New
prospects of cancer therapy based on pyroptosis and pyroptosis
inducers. Apoptosis. 29:66–85. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu R, Truax AD, Chen L, Hu P, Li Z, Chen
J, Song C, Chen L and Ting JP: Expression profile of innate immune
receptors, NLRs and AIM2, in human colorectal cancer: Correlation
with cancer stages and inflammasome components. Oncotarget.
6:33456–69. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sharma BR and Kanneganti TD: Inflammasome
signaling in colorectal cancer. Transl Res. 252:45–52. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guan X, Liu R, Wang B, Xiong R, Cui L,
Liao Y, Ruan Y, Fang L, Lu X, Yu X, et al: Inhibition of HDAC2
sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated
pyroptosis in colorectal cancer. Clin Transl Med. 14:e16922024.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun Y, Hu H, Liu Z, Xu J, Gao Y, Zhan X,
Zhou S, Zhong W, Wu D, Wang P, et al: Macrophage STING signaling
promotes NK cell to suppress colorectal cancer liver metastasis via
4-1BBL/4-1BB co-stimulation. J Immunother Cancer. 11:e0064812023.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu LS, Liu Y, Wang XW, Xu B, Lin YL, Song
Y, Dong Y, Liu JL, Wang XJ, Liu S, et al: LPS enhances the
chemosensitivity of oxaliplatin in HT29 cells via GSDMD-mediated
pyroptosis. Cancer Manag Res. 12:10397–10409. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun L, Wang J, Li Y, Kang Y, Jiang Y,
Zhang J, Qian S and Xu F: Correlation of gasdermin B staining
patterns with prognosis, progression, and immune response in
colorectal cancer. BMC Cancer. 24:5672024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou Y, Zhang W, Wang B, Wang P, Li D, Cao
T, Zhang D, Han H, Bai M, Wang X, et al: Mitochondria-targeted
photodynamic therapy triggers GSDME-mediated pyroptosis and
sensitizes anti-PD-1 therapy in colorectal cancer. J Immunother
Cancer. 12:e0080542024. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sala R, Rioja-Blanco E, Serna N,
Sánchez-García L, Álamo P, Alba-Castellón L, Casanova I,
López-Pousa A, Unzueta U, Céspedes MV, et al: GSDMD-dependent
pyroptotic induction by a multivalent CXCR4-targeted nanotoxin
blocks colorectal cancer metastases. Drug Deliv. 29:1384–1397.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xi Y, Zeng S, Tan X and Deng X: Curcumin
inhibits the activity of ubiquitin ligase Smurf2 to promote
NLRP3-dependent pyroptosis in non-small cell lung cancer cells. Int
J Oncol. 66:212025. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li L, Xing Z, Wang J, Guo Y, Wu X, Ma Y,
Xu Z, Kuang Y, Liao T and Li C: Hyaluronic acid-mediated targeted
nano-modulators for activation of pyroptosis for cancer therapy
through multichannel regulation of Ca2+ overload. Int J
Biol Macromol. 299:1401162025. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhou Y, Kong Y, Jiang M, Kuang L, Wan J,
Liu S, Zhang Q, Yu K, Li N, Le A and Zhang Z: Curcumin activates
NLRC4, AIM2, and IFI16 inflammasomes and induces pyroptosis by
up-regulated ISG3 transcript factor in acute myeloid leukemia cell
lines. Cancer Biol Ther. 23:328–335. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang Y, Wang Y, Yang Y, Zhao D, Liu R, Li
S and Zhang X: Proteomic analysis of ITPR2 as a new therapeutic
target for curcumin protection against AFB1-induced pyroptosis.
Ecotoxicol Environ Saf. 260:1150732023. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pan H, Hu T, He Y, Zhong G, Wu S, Jiang X,
Rao G, You Y, Ruan Z, Tang Z and Hu L: Curcumin attenuates
aflatoxin B1-induced ileum injury in ducks by inhibiting NLRP3
inflammasome and regulating TLR4/NF-κB signaling pathway. Mycotoxin
Res. 40:255–268. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liang WF, Gong YX, Li HF, Sun FL, Li WL,
Chen DQ, Xie DP, Ren CX, Guo XY, Wang ZY, et al: Curcumin activates
ROS signaling to promote pyroptosis in hepatocellular carcinoma
HepG2 cells. In Vivo. 35:249–257. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cheng F, He L, Wang J, Lai L, Ma L, Qu K,
Yang Z, Wang X, Zhao R, Weng L and Wang L: Synergistic
immunotherapy with a calcium-based nanoinducer: Evoking pyroptosis
and remodeling tumor-associated macrophages for enhanced antitumor
immune response. Nanoscale. 16:18570–18583. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Foroutan Z, Butler AE, Zengin G and
Sahebkar A: Curcumin and ferroptosis: A promising target for
disease prevention and treatment. Cell Biochem Biophys. 82:343–349.
2024. View Article : Google Scholar : PubMed/NCBI
|
